PAC-14028 cream 1.0%

DRUG7 trials

Sponsors

Amorepacific Corporation

Conditions

Atopic DermatitisRosaceaSeborrheic DermatitisSkin Pruritus

Phase 1

A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Pediatric Atopic Dermatitis

CompletedNCT02748993

Amorepacific CorporationAtopic Dermatitis

Start: 2016-03-31End: 2018-10-31Updated: 2018-11-20

Phase 2

A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Skin Pruritus

CompletedNCT02565134

Amorepacific CorporationSkin Pruritus

Start: 2014-10-31End: 2016-07-31Updated: 2016-07-15

A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Atopic Dermatitis

CompletedNCT02583022

Amorepacific CorporationAtopic Dermatitis

Start: 2013-06-30End: 2015-08-31Updated: 2015-10-21

A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Rosacea

CompletedNCT02583009

Amorepacific CorporationRosacea

Start: 2014-10-31Updated: 2016-09-20

A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Seborrheic Dermatitis

CompletedNCT02749383

Amorepacific CorporationSeborrheic Dermatitis

Start: 2014-02-28End: 2015-10-31Updated: 2016-04-25

A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Adults With Atopic Dermatitis

CompletedNCT02757729

Amorepacific CorporationAtopic Dermatitis

Start: 2015-10-31Updated: 2016-09-20

Phase 3

CAPTAIN-AD: Clinical Study of AmorePacific's TRPV1 Antagonist in Atopic Dermatitis

CompletedNCT02965118

Amorepacific CorporationAtopic Dermatitis

Start: 2016-11-30End: 2018-11-30Updated: 2018-11-20